Tuberculosis: Diagnostics

Tuberculosis

Volumn 87, Issue SUPPL. 1, 2007, Pages

  Cho, Sang Nae ^a   Brennan, Patrick J ^b  

^a Yonsei University College of Medicine   (South Korea)

^b Department of Ecosystem Science and Sustainability   (United States)

Author keywords

Immunodiagnosis; Molecular diagnosis; Tuberculosis

Indexed keywords

DNA; NUCLEIC ACID; RNA;

BCG VACCINATION; COST BENEFIT ANALYSIS; DRUG RESISTANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYME LINKED IMMUNOSPOT ASSAY; GENE MUTATION; HUMAN; MOLECULAR BIOLOGY; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SENSITIVITY AND SPECIFICITY; TUBERCULOSIS;

HIV INFECTIONS; HUMANS; IMMUNOLOGIC TESTS; MOLECULAR DIAGNOSTIC TECHNIQUES; MYCOBACTERIUM TUBERCULOSIS; POLYMERASE CHAIN REACTION; TUBERCULIN TEST; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

EID: 34547655417     PISSN: 14729792     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tube.2007.05.001     Document Type: Review

References (53)

1. Zhang Y., and Telenti A. Genetics of drug resistance in Mycobacterium tuberculosis. In: Hatfull G.F., and Jacobs Jr. W.R. (Eds). Molecular genetics of mycobacteria (2000), ASM Press 235-254
2. Ramaswamy S., and Musser J.M. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79 (1998) 3-29
3. Telenti A., Imboden P., Marchesi F., Lowrie D., Cole S., Colston M.J., et al. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341 (1993) 647-650
4. Pretorius G.S., Sirgel F.A., Schaaf H.S., van Helden P.D., and Victor T.C. Rifampicin resistance in Mycobacterium tuberculosis-rapid detection and implications in chemotherapy. S Afr Med J 86 (1996) 50-55
5. Zhang Y., Heym B., Allen B., Young D., and Cole S. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis. Nature 358 (1992) 591-593
6. Banerjee A., Dubnau E., Quemard A., Balasubramanian V., Um S.K., Wilson T., et al. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis. Science 263 (1994) 227-230
7. Musser J.M., Kapur V., Williams D.L., kreiswirth B.N., van Soolingen D., and van Embden J.D.A. Characterization of the catalase-peroxidase gene (katG) and inhA locus in isoniazid-resistant and susceptible strains of Mycobacterium tuberculosis by automated DNA sequencing: restricted array of mutations associated with drug resistance. J Infect Dis 173 (1996) 196-202
8. Lee A.S., Lim I.H., Tang L.L., Telenti A., and Wong S.Y. Contribution of kasA analysis to detection of isoniazid-resistant Mycobacterium tuberculosis in Singapore. Antimicrob Agents Chemother 43 (1999) 2087-2089
9. Deretic V., Philipp W., Dhandayuthapani S., Mudd M.H., Curcic R., Garbe T., et al. Mycobacterium tuberculosis is a natural mutant with an inactivated oxidative stress regulatory gene: implications for sensitivity to isoniazid. Mol Microbiol 17 (1995) 889-900
10. Telenti A., Philipp W.J., Sreevatsan S., Bernasconi C., Stockbauer K.E., Wieles B., et al. The emb operon, a gene cluster of Mycobacterium tuberculosis involved in resistance to ethambutol. Nat Med 3 (1997) 567-570
11. Ramaswamy S.V., Amin A.G., Goksel S., Stager C.E., Dou S.J., El Sahly H., et al. Molecular genetic analysis of nucleotide polymorphisms associated with ethambutol resistance in human isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 44 (2000) 326-336
12. Finken M., Kirschner P., Meier A., Wrede A., and Bottger E.C. Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot. Mol Microbiol 9 (1993) 1239-1246
13. Cooksey R.C., Morlock G.P., McQeen A., Glickman S.E., and Crawford J.T. Characterization of streptomycin resistance mechanisms among Mycobacterium tuberculosis isolates from patients in New York City. Antimicrob Agents Chemother 40 (1996) 1186-1188
14. Katsukawa C., Tamaru A., Miyata Y., Abe C., Makino M., and Suzuki Y. Characterization of the rpsL and rrs genes of streptomycin-resistant clinical isolates of Mycobacterium tuberculosis in Japan. J Appl Microbiol 83 (1997) 634-640
15. Scorpio A., and Zhang Y. Mutations in pncA, a gene encoding pyrazinamidase/nicotinamidase, cause resistance to the antibuterculous drug pyrazinamide in tubercle bacillus. Nat Med 2 (1996) 662-667
16. Scorpio A., Lindholm-Levy P., Heifets L., Gilman R., Siddiqi S., Cynamon M., et al. Characterization of pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 41 (1997) 540-543
17. Takiff H.E., Salazar L., Guerrero C., Philipp W., Huang W.M., Kreiswirth B., et al. Cloning and nucleotide sequence of Mycobacterium tuberculosis gyrA and gyrB genes and detection of quinolone resistance mutations. Antimicrob Agents Chemother 38 (1994) 773-780
18. Pitaksajjakul P., Wongwit W., Punprasit W., Eampokalap B., Peacock S., and Ramasoota P. Mutations in the gyrA and gyrB genes of fluoroquinolone-resistant Mycobacterium tuberculosis from TB patients in Thailand. Southeast Asian J Trop Med Public Health 36 Supl 4 (2005) 228-237
19. Suzuki Y., Katsukawa C., Tamaru A., Abe C., Makino M., Mizuguchi Y., et al. Detection of kanamycin-resistant Mycobacterium tuberculosis by identifying mutations in the 16S rRNA gene. J Clin Microbiol 36 (1998) 1220-1225
20. Alangaden G.J., Kreiswirth B.N., Aouad A., Khetarpal M., Igno F.R., Moghazeh S.L., et al. Mechanism of resistance to amikacin and kanamycin in Mycobacterium tuberculosis. Antimicrob Agents Chemother 42 (1998) 1295-1297
21. Rengarajan J., Sassetti C.M., Naroditskaya V., Sloutsky A., Bloom B.R., and Rubin E.J. The folate pathway is a target for resistance to the drug para-aminosalicylic acid (PAS) in mycobacteria. Mol Microbiol 53 (2004) 275-282
22. Heym B., Honore N., Truffot-Pernot C., Banerjee A., Schurra C., Jacobs Jr. W.R., et al. Implications of multidrug resistance for the future of short-course chemotherapy of tuberculosis: a molecular study. Lancet 344 (1994) 293-298
23. Lee H., Cho S.N., Bang H.E., Lee J.H., Bae G.H., Kim S.J., et al. Molecular analysis of rifampin-resistant Mycobacterium tuberculosis isolated from Korea by PCR-SSCP sequence analysis. Int J Tuberc Lung Dis 2 (1998) 585-589
24. Williams D.L., Waguespack C., Eisenach K., Crawford J.T., Portaels F., Salfinger M., et al. Characterization of rifampin-resistance in pathogenic mycobacteria. Antimicrob Agents Chemother 38 (1994) 2380-2386
25. Victor T.C., Jordaan A.M., van Rie A., van der Spuy G.D., Richardson M., van Helden P.D., et al. Detection of mutations in drug resistance genes of Mycobacterium tuberculosis by a dot-blot hybridization strategy. Tuber Lung Dis 79 (1999) 343-348
26. Cooksey R.C., Morlock G.P., Glickman S., and Crawford J.T. Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis from New York City. J Clin Microbiol 35 (1997) 1281-1283
27. Giannoni F., Iona E., Sementilli F., Brunori L., Pardini M., Migliori G.B., et al. Evaluation of a new line probe assay for rapid identification of gyrA mutations in Mycobacterium tubeculosis. Antimicrob Agents Chemother 49 (2005) 2928-2933
28. Tang X., Morris S.L., Langone J.J., and Bockstahler L.E. Microarray and allele specific PCR detection of point mutations in Mycobacterium tuberculosis genes associated with drug resistance. J Microbiol Methods 63 (2005) 318-330
29. Gryadunov D., Mikhailovich V., Lapa S., Roudinskii N., Donnikov M., Pan'kov S., et al. Evaluation of hybridization on oligonucleotide microarrays for analysis of drug-resistant Mycobacterium tuberculosis. Clin Microbiol Infect 11 (2005) 531-539
30. Park H., Song E.J., Song E.S., Lee E.Y., Kim C.M., Jeong S.H., et al. Comparison of a conventional antimicrobial susceptibility assay to an oligonucleotide chip system for detection of drug resistance in Mycobacterium tuberculosis isolates. J Clin Microbiol 44 (2006) 1619-1624
31. Suzuki Y., Suzuki A., Tamaru A., Katsukawa C., and Oda H. Rapid detection of pyrazinamide-resistant Mycobacterium tuberculosis by a PCR-based in vitro system. J Clin Microbiol 40 (2002) 501-507
32. Piatek A.S., Tyagi S., Pol A.C., Telenti A., Miller L.P., Kramer F.R., et al. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat Biotechnol 16 (1998) 359-363
33. Victor T.C., Lee H., Cho S.N., Jordaan A.M., van der Spuy G., van Helden P.D., et al. Molecular detection of early appearance of drug resistance during Mycobacterium tuberculosis infection. Clin Chem Lab Med 40 (2002) 876-881
34. Davidson R.N. Childhood tuberculosis-problems ahead. Trans R Soc Trop Med Hyg 94 (2000) 5-6
35. Nelson L.J., and Wells C.D. Global epidemiology of childhood tuberculosis. Int J Tuberc Lung Dis 8 (2004) 636-647
36. Starke J.R. Tuberculosis in infants and children. In: Schlossberg D. (Ed). Tuberculosis & nontuberculous mycobacterial infections. 5th ed (2000), McGraw-Hill 365-383
37. Bonington A., Strang J.I., Klapper P.E., Hood S.V., Rubombora W., Penny M., et al. Use of Roche AMPLICOR Mycobacterium tuberculosis PCR in early diagnosis of tuberculous meningitis. J Clin Microbiol 36 (1998) 1251-1254
38. Pahwa R., Hedau S., Jain S., Jain N., Arora V.M., Kumar N., et al. Assessment of possible tuberculous lymphadenopathy by PCr compared to non-molecular methods. J Med Microbiol 54 (2005) 873-878
39. Montenegro S.H., Gilman R.H., Sheen P., Cama R., Caviedes L., Hopper T., et al. Improved detectionof Mycobacterium tuberculosis in Peruvian children by use of a heminested IS6110 polymerase chain reaction assay. Clin Infect Dis 36 (2003) 16-23
40. Kato-Maeda M., and Small P.M. HIV and tuberculosis. In: Schlossberg D. (Ed). Tuberculosis & nontuberculous mycobacterial infections. 5th ed (2006), McGraw Hill 388-399
41. Palmieri F., Girardi E., Pellicelli A.M., Rianda A., Bordi E., Rizzi E.B., et al. Pulmonary tuberculosis in HIV-infected patients presenting with normal chest radiograph and negative sputum smear. Infection 30 (2002) 68-74
42. Holmes C.B., Losina E., Walensky R.P., Yazdanpanah Y., and Freedberg K.A. Review of human immunodeficiency virus type-1 related opportunistic infections in sub-Saharan Africa. Clin Infect Dis 36 (2003) 652-662
43. Kambashi B., Mbulo G., McNerney R., Tembwe R., Kambashi A., Tihon V., et al. Utility of nucleic acid amplification techniques for the diagnosis of pulmonary tuberculosis in sub-Saharan Africa. Int J Tuberc Lung Dis 5 (2001) 364-369
44. Kivihya-Ndugga L., van Cleeff M., Juma E., Kimwomi J., Githui W., Oskam L., et al. Comparison of PCR with the routine procedure for diagnosis of tuberculosis in a population with high prevalence of tuberculosis and human immunodeficiency virus. J Clin Microbiol 42 (2004) 1012-1015
45. Jones D., and Havlir D.V. Nontuberculous mycobacteria in the HIV infected patient. Clin Chest Med 23 (2002) 665-674
46. Lee H., Bang H.E., Bai G.H., and Cho S.N. Novel polymorphic region of the rpoB gene containing Mycobacterium species-specific sequences and its use in identification of mycobacteria. J Clin Microbiol 41 (2003) 2213-2218
47. Mokrousov I., Bhanu N.V., Suffys P.N., Kadival G.V., Yap S.F., Cho S.N., et al. Multicenter evaluation of reverse line blot assay for detection of drug resistance in Mycobacterium tuberculosis clinical isolates. J Microbiol Methods 57 (2004) 323-335
48. Chan E.D., Heifets L., and Iseman M.D. Immunologic diagnosis of tuberculosis: a review. Tuberc Lung Dis 80 (2000) 131-140
49. Lyashchenko K., Colangeli R., Houde M., Al Jahdali H., Menzies D., and Gennaro M.L. Heterogenous antibody responses in tuberculosis. Infect Immun 66 (1998) 3936-3940
50. Brock I., Munk M.E., Kok-Jensen A., and Andersen P. Performance of whole blood IFN-γ test for tuberculosis diagnosis based on PPD or the specific antigens ESAT-6 and CFP-10. Int J Tuberc Lung Dis 5 (2001) 462-467
51. Kang Y.A., Lee H.W., Yoon H.I., Cho B.L., Han S.K., Shim Y.S., et al. Discrepancy between the tuberculin skin test and the whole-blood interferon γ assay for the diagnosis of latent tuberculosis infection in an intermediate tuberculosis-burden country. J Am Med Assoc 293 (2005) 2756-2761
52. Diel R., Nienhaus A., Lange C., Meywald-Walter K., Forβbohm M., and Schaberg T. Tuberculosis contact investigation with a new, specific blood test in a low-incidence population containing a high proportion of BCG-vaccinated persons. Respir Res 7 (2006) 77
53. Meier T., Eulenbruch H.P., Wrighton-Smith, Enders G., and Regnath T. Sensitivity of a new commercial enzyme-linked immunospot assay (T SPOT-TB) for diagnosis of tuberculosis in clinical practice. Eur J Clin Microbiol Infect Dis 24 (2005) 529-536